Begleittherapie bei 5-Fluorouracil, Capezitabine, Taxanen, Irinotecan und Platinumsalzen
Crossref DOI link: https://doi.org/10.1007/978-3-662-46764-0_297-1
Published Online: 2020-12-05
Published Print: 2020
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Joerger, Markus
Cerny, Thomas
Text and Data Mining valid from 2020-01-01
Version of Record valid from 2020-01-01
Chapter History
Received: 26 January 2019, 00:00:00
Accepted: 6 June 2019, 00:00:00
First Online: 5 December 2020